MedTrace Logo

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

NCT06234488 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2026-01-12

No results posted yet for this study

Summary

There is no granular retrospective data on breast cancer in transgender and gender-diverse (TGD) persons from a contemporary and diverse American cohort. The purpose of this investigation is to aggregate data from multiple institutions to describe the risk, diagnosis, management, and outcomes of TGD persons with breast cancer in effort to identify opportunities for future intervention studies to eliminate breast cancer disparities for this population.

Conditions

  • Breast Cancer
  • Breast Neoplasms
  • Breast Adenocarcinoma
  • Breast Cancer Stage
  • Breast Cancer Stage IV
  • Breast Cancer Invasive
  • Breast Cancer in Situ

Sponsors & Collaborators

  • Medical College of Wisconsin

    lead OTHER

Principal Investigators

  • Chandler S Cortina · The Medical College of Wisconsin

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-08
Primary Completion
2024-11-01
Completion
2026-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06234488 on ClinicalTrials.gov